Status:

COMPLETED

Healthy Food Prescription Incentive Program

Lead Sponsor:

University of Calgary

Collaborating Sponsors:

Alberta Innovates Health Solutions

Alberta Health services

Conditions:

Diet, Healthy

Diabetes Mellitus, Type 2

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

It is important for individuals with type 2 diabetes (T2DM) to adhere to a healthy dietary pattern to maintain optimal blood glucose levels and overall health. The increasing costs of healthy foods, h...

Detailed Description

It is vital for individuals with type 2 diabetes (T2DM) to adhere to a healthy dietary pattern to maintain optimal blood glucose levels and overall health. However, the increasing costs of healthy foo...

Eligibility Criteria

Inclusion

  • Adults (18-85 years) with type 2 diabetes (or diabetes of unknown etiology)
  • Persistent hyperglycemia (i.e. hemoglobin A1C 6.5-12%)
  • Are currently experiencing food insecurity and/or report that it is difficult/very difficult to make ends meet
  • Can communicate in English or have someone to translate

Exclusion

  • A1c \<6.5% or \> 12% given the recommendation for anti-hyperglycemic treatment escalation for those with A1c\>12%
  • Reside in a facility that provides meals (e.g., shelter, long-term care, prison)
  • Exhibit signs/symptoms of metabolic decompensation (weight loss, polyuria, polydipsia)
  • Diagnosis of eating disorder(s) (e.g., anorexia nervosa, bulimia)
  • Have experienced diabetic ketoacidosis or a hyperglycemic hyperosmolar emergency in the past year
  • Experienced a hypoglycemic event in the past 3 months
  • Are trying to conceive, pregnant and/or breastfeeding
  • Are currently participating in other clinical trials
  • A household member is currently or has previously participated in this trial
  • Unwilling/unable to shop in study-affiliated supermarkets for the next 12 months
  • Plan to leave for Canada for more than 2 weeks in the next 12 months
  • Unable to complete data collection at follow-up (e.g., due to moving)

Key Trial Info

Start Date :

May 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 7 2025

Estimated Enrollment :

597 Patients enrolled

Trial Details

Trial ID

NCT04725630

Start Date

May 29 2021

End Date

March 7 2025

Last Update

December 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Primary Care Clinics

Multiple Locations, Alberta, Canada